Every GLP-1 Drug Ranked by Effectiveness (2025)

There are several GLP-1 based medications, and they are not interchangeable. They differ in strength, dosing, approved uses, and cost. This guide ranks the main options and, more importantly, explains why the "best" one depends on your goal.

Quick answer

For weight loss, tirzepatide (a dual GIP/GLP-1 agonist sold as Mounjaro for diabetes and Zepbound for weight management) generally produced the largest average weight loss in clinical trials, ahead of semaglutide (Ozempic/Wegovy). Semaglutide is the next strongest and is extremely well established. Older agents like liraglutide, dulaglutide, and exenatide are effective but generally produce less weight loss. The single "best" drug depends on whether your priority is weight loss, diabetes control, dosing convenience, tolerability, or cost.

How the GLP-1 drugs compare

The major FDA-approved options fall into a rough hierarchy for weight loss, based on trial results for the drug classes studied:

Note that tirzepatide is technically a dual agonist (it acts on two receptors, GIP and GLP-1), which is part of why it is so potent, while the others act on GLP-1 alone. They are different molecules, not versions of the same drug.

1. Tirzepatide (Mounjaro / Zepbound)

For weight loss, tirzepatide tops the list. In the trials of this drug class (the SURMOUNT program), it produced the largest average weight loss of the approved options. Its dual mechanism, acting on both GIP and GLP-1 pathways, is thought to underlie its strength. It is dosed once weekly. Mounjaro is approved for type 2 diabetes; Zepbound is approved for weight management.

2. Semaglutide (Ozempic / Wegovy / Rybelsus)

Semaglutide is the most famous GLP-1 and a very strong performer. In its weight-management trials (the STEP program), it produced substantial weight loss, generally less than tirzepatide but well ahead of older agents. It is dosed once weekly as an injection (Ozempic for diabetes, Wegovy for weight management), with an oral daily tablet form (Rybelsus) for diabetes. Its long track record and flexibility make it a default for many people.

3. Dulaglutide (Trulicity)

Dulaglutide is a once-weekly GLP-1 used for type 2 diabetes. It is effective for blood sugar with a moderate weight effect, less than semaglutide or tirzepatide. It is a solid diabetes option but not a first pick when maximum weight loss is the goal.

4. Liraglutide (Victoza / Saxenda)

Liraglutide is an older GLP-1, notable for being dosed daily rather than weekly. Victoza is for diabetes and Saxenda for weight management. It produces meaningful but generally smaller weight loss than semaglutide, and the daily injection is less convenient than the weekly options.

5. Exenatide (Byetta / Bydureon)

Exenatide is one of the earlier GLP-1 medications, used for type 2 diabetes. It is effective for blood sugar but generally produces less weight loss than the newer agents and is less commonly chosen for weight goals today.

Which GLP-1 is best for you?

The ranking above is for weight loss, but "best" is personal:

• Maximum weight loss: tirzepatide leads, with semaglutide close behind.
• Diabetes with weight benefit: tirzepatide or semaglutide are strong; dulaglutide is a good weekly diabetes option.
• Oral preference: Rybelsus (oral semaglutide) is the main oral option, for diabetes.
• Tolerability: all share GI side effects; individual response varies, so the "best tolerated" one differs by person.
• Cost and access: prices and coverage differ, and this often shapes the real-world choice as much as potency.

How to choose with a clinician

The right GLP-1 is a decision to make with a licensed prescriber who weighs your goals, health history, tolerability, and budget. For people focused on weight management, FormBlends offers compounded semaglutide through licensed prescribers and a provider comparison tool to compare options side by side.

Frequently asked questions

Which GLP-1 drug is best for weight loss?

Tirzepatide generally produced the largest average weight loss in trials, with semaglutide next. Older agents produce less.

What is the strongest GLP-1?

For weight loss, tirzepatide (a dual GIP/GLP-1 agonist) led the trials of its class, ahead of semaglutide.

Are all GLP-1 drugs the same?

No. They are different molecules with different strengths, dosing, and approved uses. Tirzepatide is a dual agonist; the others act on GLP-1 alone.

Which GLP-1 is best for diabetes?

Tirzepatide and semaglutide are strong for diabetes with weight benefits; dulaglutide is a solid weekly diabetes option. Your prescriber decides based on your situation.

Is there an oral GLP-1?

Yes. Rybelsus is oral semaglutide, approved for type 2 diabetes.

Which has the fewest side effects?

All share gastrointestinal side effects, and individual tolerability varies, so there is no universal answer. Slow titration helps with any of them.

How do I choose?

Decide with a licensed prescriber based on your goal (weight vs diabetes), tolerability, dosing preference, and cost.

Related guides

• Every Weight Loss Drug Ranked: Phentermine to Retatrutide
• Every Healing Peptide Ranked: BPC-157, TB-500, GHK-Cu & More
• Best Online Glp-1 Weight Loss Program 2026 Ranked
• 15 Best Online GLP-1 Providers Ranked by Price, Quality & Reviews (2025)
• GLP-1 vs Phentermine: Two Different Drug Classes, Two Different Use Cases
• Weight Loss With vs Without GLP-1: Do You Need the Drug?

Sources

• New England Journal of Medicine, SURMOUNT-1 (tirzepatide) and STEP 1 (semaglutide) obesity trials - https://www.nejm.org/doi/full/10.1056/NEJMoa2206038
• National Institute of Diabetes and Digestive and Kidney Diseases: Prescription Medications to Treat Overweight and Obesity - https://www.niddk.nih.gov/health-information/weight-management/prescription-medications-treat-overweight-obesity